Brachytherapy
Volume 7, Issue 1 , Pages 7-11 , January 2008

High-dose-rate brachytherapy for large prostate volumes (≥50cc)—Uncompromised dosimetric coverage and acceptable toxicity

Received 12 June 2007 ,Revised 28 September 2007 ,Accepted 10 October 2007.

References 

  1. Wang H, Wallner K, Sutlief S, et al. Transperineal brachytherapy in patients with large prostate glands. Int J Cancer. 2000;90(4):199–205
  2. Stone NN, Stock RG. Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): Dosimetric analysis of implant quality. Int J Radiat Oncol Biol Phys. 2000;46(5):1199–1204
  3. McNeely LK, Stone NN, Presser J, et al. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. Int J Radiat Oncol Biol Phys. 2004;58(1):292–299
  4. Lee N, Wuu CS, Brody R, et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48(5):1457–1460
  5. Locke J, Ellis W, Wallner K, et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys. 2002;52(3):712–719
  6. Landis DM, Schultz D, Cormack R, et al. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology. 2005;65(4):750–754
  7. Thomas MD, Cormack R, Tempany CM, et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):905–908
  8. Crook J, McLean M, Catton C, et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002;52(2):452–460
  9. Kucway R, Vicini F, Huang R, et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol. 2002;167(6):2443–2447
  10. Whittington R, Broderick GA, Arger P, et al. The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1999;44(5):1107–1110
  11. Wallner K, Ellis W, Russell K, et al. Use of TRUS to predict pubic arch interference of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43(3):583–585
  12. Bellon J, Wallner K, Ellis W, et al. Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43(3):579–581
  13. Tincher SA, Kim RY, Ezekiel MP, et al. Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants. Int J Radiat Oncol Biol Phys. 2000;47(2):361–363
  14. Fu L, Liu H, Ng WS, et al. Hybrid dosimetry: Feasibility of mixing angulated and parallel needles in planning prostate brachytherapy. Med Phys. 2006;33(5):1192–1198
  15. SAS Institute Inc . SAS Online Doc®, version 8. Cary, NC: SAS Institute Inc; 1999;
  16. Blasko JC, Grimm PD, Sylsvester JE, et al. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol. 2000;57(3):273–278
  17. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998;160(4):1379–1382
  18. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005;61(5):1306–1316

PII: S1538-4721(07)00284-X

doi: 10.1016/j.brachy.2007.10.005

Brachytherapy
Volume 7, Issue 1 , Pages 7-11 , January 2008

Article Tools

* Image Usage & Resolution